Sodium alginate supplementation can alleviate non-alcoholic fatty liver disease in rats by restoring hepatic lipid metabolism and gut microbiota
{{output}}
Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent metabolic disorder with no approved pharmacological treatments. Several studies indicate that sodium alginate (SA) may hold promising potential in the treatment of NAFLD. However, whether SA can se... ...
